Exploring the use of bulevirtide as a new weapon against hepatitis D
In a multicenter phase 3 trial, researchers at the MHH have demonstrated the efficacy and safety of the drug bulevirtide, which prevents HD viruses from entering the liver. This paves the way for a drug therapy of the particularly ...
Jun 22, 2023
0
12